In conclusion, further research is necessary to elucidate the potential roles of PXR and CAR in the development and progression of NAFLD/NASH, as well as to determine their temporal functions in the various stages of this complex disease. The gene discussed is NR1I2; the disease is metabolic dysfunction-associated steatotic liver disease.